Pralatrexate and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pralatrexate (pralatrexate) and Ondansetron (ondansetron). Common drug interactions include blood sodium decreased among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Pralatrexate and Ondansetron. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Pralatrexate?

Pralatrexate has active ingredients of pralatrexate. eHealthMe is studying from 231 Pralatrexate users. Check the latest studies of Pralatrexate.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

On Jul, 18, 2026

11 people who take Pralatrexate and Ondansetron together, and have interactions are studied.

Pralatrexate and Ondansetron drug interactions.

What are the common drug interactions of Pralatrexate and Ondansetron, by gender? *:

female:

Blood sodium decreased
Haematocrit decreased
Haemoglobin decreased
Oral candidiasis (fungal infection of mouth)
Thrombocytopenia (decrease of platelets in blood)
Blood albumin decreased
Blood chloride decreased
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

male:

Dyspnoea (difficult or laboured respiration)
Blood creatinine increased
White blood cell count decreased
Abdominal pain
Anaemia (lack of blood)
Asthenia (weakness)
B-cell lymphoma (blood cancer affecting b cells)
Blood albumin decreased
Blood chloride decreased
Blood urea increased

What are the common drug interactions of Pralatrexate and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea (difficult or laboured respiration)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Respiratory failure (inadequate gas exchange by the respiratory system)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
B-cell lymphoma (blood cancer affecting b cells)
Blood creatinine increased
Confusional state
Cough
Failure to thrive (inadequate weight gain and physical growth in children)
Haematocrit decreased

60+:

Blood albumin decreased
Blood chloride decreased
Sepsis (a severe blood infection that can lead to organ failure and death)
Thrombocytopenia (decrease of platelets in blood)
Abdominal pain
Anaemia (lack of blood)
Asthenia (weakness)
Blood creatinine increased
Blood urea increased
Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 36.36%
T-Cell Lymphoma (a blood cell cancer): 1 person, 9.09%
Pulmonary Oedema (fluid accumulation in the lungs): 1 person, 9.09%
Pneumonia: 1 person, 9.09%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 9.09%
Pain: 1 person, 9.09%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 1 person, 9.09%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 9.09%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 9.09%
Hodgkin's Disease Recurrent (cancer originating from white blood cells -recurrent): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pralatrexate and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously